| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
38,200 |
3,095 |
$1.57M |
| J0606 |
Injection, etelcalcetide, 0.1 mg |
7,520 |
561 |
$43K |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
8,670 |
2,352 |
$14K |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
2,949 |
310 |
$4K |
| 80051 |
|
1,510 |
1,446 |
$1.40 |
| 82310 |
|
3,859 |
2,890 |
$1.03 |
| 82565 |
|
3,097 |
2,889 |
$1.02 |
| 84520 |
|
6,540 |
2,960 |
$0.79 |
| 85018 |
|
5,848 |
2,869 |
$0.00 |
| 87340 |
|
1,173 |
1,115 |
$0.00 |
| 85027 |
|
3,332 |
2,921 |
$0.00 |
| 82728 |
|
1,773 |
1,693 |
$0.00 |
| 86704 |
|
438 |
423 |
$0.00 |
| 82040 |
|
3,097 |
2,913 |
$0.00 |
| 84132 |
|
4,687 |
2,060 |
$0.00 |
| 83550 |
|
1,775 |
1,691 |
$0.00 |
| 82435 |
|
1,134 |
1,110 |
$0.00 |
| 86803 |
|
509 |
491 |
$0.00 |
| 86706 |
|
440 |
425 |
$0.00 |
| 84075 |
|
3,079 |
2,926 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
103 |
102 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
251 |
243 |
$0.00 |
| 84460 |
|
3,213 |
2,929 |
$0.00 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
6,372 |
2,209 |
$0.00 |
| 83540 |
|
1,775 |
1,691 |
$0.00 |
| 82374 |
|
1,147 |
1,121 |
$0.00 |
| 83970 |
|
1,086 |
1,049 |
$0.00 |
| 90662 |
|
144 |
138 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
25,750 |
2,289 |
$0.00 |
| 84100 |
|
3,782 |
2,921 |
$0.00 |
| 84295 |
|
1,146 |
1,102 |
$0.00 |
| 85610 |
|
38 |
12 |
$0.00 |
| 90682 |
|
18 |
16 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
61 |
13 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
25 |
25 |
$0.00 |